2BQ-27560-05285
4 vaccinations
4 coded responses
24 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 41-45
- ZIP prefix
- 481 / MI
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Registered in v-safe
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
-
2021-04-14
Dose 2 — Pfizer-BioNTech
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-14
- 2021-05-21
- 2021-05-26
- 2021-07-14
-
2021-10-13
Survey response — 6 months, dose 2MedDRA: Ageusia, Anosmia, Loss of personal independence in daily activities, Pain, Pyrexia, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: I tested positive for covid 9/29 and got sick for 4 days with fever and body aches. Lost taste and smell (partially recovered to date). Started improving steadily from 10/3 and returned cautiously to normal activity from 10/4MedDRA releases: 2024-11 · check-in free text available
-
2021-10-13
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-20
Callback requested for05:00PM ET
- 2021-12-01
-
2021-12-31
Dose 3 — Moderna
-
2022-04-16
Survey response — 12 months, dose 2MedDRA: Fatigue, Parosmia, Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested positive to Covid-19 on 2/22/2022 Phantosmia, mild fatigue, low feverMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-19
Call successfulNot applicable - Accidental Reporting
-
2022-09-02
Dose 4 — Moderna
- 2022-10-18
-
2022-12-02
Survey response — 3 months, dose 4MedDRA: Fatigue, Rhinorrhoea, SARS-CoV-2 test negative, Unevaluable event, Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had some viral infection with temperature, fatigue, runny nose, but tested negative for Covid in a rapid testMedDRA releases: 2024-11 · check-in free text available
-
2023-03-03
Survey response — 6 months, dose 4MedDRA: Cough, Gastroenteritis viral, Influenza — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-14 | Pfizer-BioNTech | |
| 3 | 2021-12-31 | Moderna | No |
| 4 | 2022-09-02 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 10 — 6 months, dose 2
Symptoms: I tested positive for covid 9/29 and got sick for 4 days with fever and body aches. Lost taste and smell (partially recovered to date). Started improving steadily from 10/3 and returned cautiously to normal activity from 10/4
Release 11 — 12 months, dose 2
Symptoms: Tested positive to Covid-19 on 2/22/2022 Phantosmia, mild fatigue, low fever
Release 12 — 3 months, dose 4
Symptoms: I had some viral infection with temperature, fatigue, runny nose, but tested negative for Covid in a rapid test
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Loss of personal independence in daily activities | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Parosmia | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release